Chronic Lymphocytic Leukemia Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

EHA 2016: The progress of CLL research: towards targeted therapy
Kostas Stamatopoulos, MD, PhD from CERTH Institute of Applied Biosciences, Thessaloniki, Greece discusses the progress of research in chronic lymphocytic leukemia (CLL). Dr Stamatopoulos points out ho... Author: VJHemOnc Added: 06/21/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2016 Category: Cancer & Oncology Source Type: podcasts

Next steps for advancing the molecular stratification of CLL
Anna Schuh, MD, PhD, from the University of Oxford, UK, gives an overview of her talk on the advances in the molecular stratification of chronic lymphocytic leukemia (CLL). The focus of the talk was t... Author: VJHemOnc Added: 06/21/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2016 Category: Cancer & Oncology Source Type: podcasts

B-cell receptor and function in CLL
Francesco Forconi, MD, PhD from the University of Southampton, Southampton, UK gives an overview of his talk on the structure and function of the B-cell receptor in chronic lymphocytic leukemia (CLL) ... Author: VJHemOnc Added: 06/21/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2016 Category: Cancer & Oncology Source Type: podcasts

ASCO 2016 highlights for CLL
William Wierda, MD, PhD from the University of Texas MD Anderson Cancer Center, Houston, TX discusses his highlights for chronic lymphocytic leukemia (CLL) from the American Society of Oncology (ASCO)... Author: VJHemOnc Added: 06/16/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 16, 2016 Category: Cancer & Oncology Source Type: podcasts

The risk of infection for CLL patients receiving idelalisib
William Wierda, MD, PhD from the University of Texas MD Anderson Cancer Center, Houston, TX discusses the safety of idelalisib for chronic lymphocytic leukemia (CLL). Dr Wierda outlines the risk of in... Author: VJHemOnc Added: 06/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 15, 2016 Category: Cancer & Oncology Source Type: podcasts

ASCO 2016: The risk of infection for CLL patients receiving idelalisib
William Wierda, MD, PhD from the University of Texas MD Anderson Cancer Center, Houston, TX discusses the safety of idelalisib for chronic lymphocytic leukemia (CLL). Dr Wierda outlines the risk of in... Author: VJHemOnc Added: 06/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 15, 2016 Category: Cancer & Oncology Source Type: podcasts

Side effects of idelalisib in CLL and how to manage them
Jennifer Brown, MD, PhD from the Dana-Farber Cancer Institute, Boston, MA outlines the side effects that may occur in chronic lymphocytic leukemia (CLL) patients treated with idealisib and how to mana... Author: VJHemOnc Added: 06/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 15, 2016 Category: Cancer & Oncology Source Type: podcasts

Targeted therapies for CLL: new data and unanswered questions
Jennifer Brown, MD, PhD from the Dana-Farber Cancer Institute, Boston, MA gives an overview of her talk on targeted therapy in chronic lymphocytic leukemia (CLL) held at the American Society of Oncolo... Author: VJHemOnc Added: 06/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 15, 2016 Category: Cancer & Oncology Source Type: podcasts

Debate: Optimal approach for the management of CLL patients with del(17p) - Novel Agents
In this presentation from "Great Debates and Updates in Hematologic Malignancies 2016", Dr. Paul Barr argues that the optimal treatment for chronic lymphocytic leukemia (CLL) patients with a 17p delet... Author: imedex Added: 05/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - May 22, 2016 Category: Cancer & Oncology Source Type: podcasts

Debate: Optimal approach for the management of CLL patients with del(17p) - Ibrutinib
In this presentation from "Great Debates and Updates in Hematologic Malignancies 2016", Dr. Jacqueline Barrientos argues that ibrutinib is the optimal treatment for chronic lymphocytic leukemia (CLL) ... Author: imedex Added: 05/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - May 22, 2016 Category: Cancer & Oncology Source Type: podcasts

Advances in the molecular stratification of chronic lymphocytic leukemia
Anna Schuh, MD, PhD, from the University of Oxford, UK, gives an overview of her talk on the advances in the molecular stratification of chronic lymphocytic leukemia (CLL). The focus of the talk was t... Author: VJHemOnc Added: 05/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2016 Category: Cancer & Oncology Source Type: podcasts

CLL case studies presented at BSH/ISH 2016
Andrew Zelenetz, MD, PhD, from Memorial Sloan-Kettering Cancer Center, New York, NY gives an overview of the case studies on chronic lymphocytic leukemia (CLL) he presented at the 36th World Congress ... Author: VJHemOnc Added: 05/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2016 Category: Cancer & Oncology Source Type: podcasts

Side-effects profile of venetoclax (ABT-199)
Prof. John Gribben, from the Barts Cancer Institute, London, UK discusses with Deborah Sims, a chronic lymphocytic leukaemia (CLL) patient, the side-effects profile of venetoclax (ABT-199). Deborah is... Author: PatientPowerEU Added: 04/11/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 11, 2016 Category: Cancer & Oncology Source Type: podcasts

The first consultation before starting treatment with venetoclax (ABT-199)
Deborah Sims is a young chronic lymphocytic leukaemia (CLL) patient, undertaking a clinical trial of obinutuzumab and venetoclax (ABT-199). Here you can see Deborah's first consultation with Prof. Joh... Author: PatientPowerEU Added: 04/11/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 11, 2016 Category: Cancer & Oncology Source Type: podcasts

How this trial has affected Deborah and her family
Deborah Sims is a young chronic lymphocytic leukaemia (CLL) patient, undertaking a clinical trial of obinutuzumab and venetoclax (ABT-199). Here, Deborah talks about the impact this clinical has had o... Author: PatientPowerEU Added: 04/11/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 11, 2016 Category: Cancer & Oncology Source Type: podcasts